Res j recent sci
Alternatively, GSH can be measured in samples not pre-treated with NEM as total GSH (tGSH, i.e., GSH+ GSSG) by the GSH-recycling method [35]
2019;68[Suppl 1]:244-OR
Semaglutide is clinically indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity such as Type 2 diabetes, hypertension, high cholesterol, or cardiovascular disease
A higher level of oxidative stress as evidenced by elevated plasma malondialdehyde levels and low levels of GSH, -tocotrienol and GSH peroxidase activity in patients under 45 years old may play a role in the development of premature coronary artery disease and be potential biomarkers for premature coronary artery disease (153)
Clinical Evidence: What Studies Show About GLP-1 and Heart Health The SUSTAIN-6 trial, a landmark study published in 2016, examined semaglutide's cardiovascular effects in people with type 2 diabetes and existing heart disease or high risk